Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases.
Mensa-Vilaró A, Bravo García-Morato M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, González-Roca E, Fuster JL, Alsina L, Mutchinick OM, Balderrama-Rodríguez A, Ramos E, Modesto C, Mesa-Del-Castillo P, Ortego-Centeno N, Clemente D, Souto A, Palmou N, Remesal A, Leslie KS, Gómez de la Fuente E, Yadira Bravo Gallego L, Campistol JM, Dhouib NG, Bejaoui M, Dutra LA, Terreri MT, Mosquera C, González T, Cañellas J, García-Ruiz de Morales JM, Wouters CH, Bosque MT, Cham WT, Jiménez-Treviño S, de Inocencio J, Bloomfield M, Pérez de Diego R, Martínez-Pomar N, Rodríguez-Pena R, González-Santesteban C, Soler-Palacín P, Casals F, Yagüe J, Allende LM, Rodríguez-Gallego JC, Colobran R, Martínez-Martínez L, López-Granados E, Aróstegui JI. Mensa-Vilaró A, et al. J Allergy Clin Immunol. 2019 Jan;143(1):359-368. doi: 10.1016/j.jaci.2018.09.009. Epub 2018 Sep 29. J Allergy Clin Immunol. 2019. PMID: 30273710 Free article. Clinical Trial.
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
Ochoa E, Martin JE, Assasi S, Beretta L, Carreira P, Guillén A, Simeón CP, Koumakis E, Dieude P, Allanore Y, García-Hernández FJ, Espinosa G, Castellví I, Trapiella JL, Rodriguez L, González-Gay MÁ, Egurbide MV, Sáez L, Callejas-Rubio JL, Vargas-Hitos JA, Hunzelmann N, Riemekasten G, Witte T, Distler JH, Kreuter A, Lunardi C, Santaniello A, Tan FK, Shiels PG, Herrick A, Worthington J, Vonk MC, Koeleman BP, Radstake TR, Mayes MD, Martin J; Spanish Scleroderma Group. Ochoa E, et al. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S31-5. Epub 2015 Aug 27. Clin Exp Rheumatol. 2015. PMID: 26314374
The complex HLA-E-nonapeptide in Behçet disease.
Castaño-Núñez ÁL, Montes-Cano MA, García-Lozano JR, Ortego-Centeno N, García-Hernández FJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Gómez de la Torre R, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF. Castaño-Núñez ÁL, et al. Front Immunol. 2023 Aug 10;14:1080047. doi: 10.3389/fimmu.2023.1080047. eCollection 2023. Front Immunol. 2023. PMID: 37638008 Free PMC article.
Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.
Ortiz-Fernández L, Carmona FD, López-Mejías R, González-Escribano MF, Lyons PA, Morgan AW, Sawalha AH, Merkel PA, Smith KGC, González-Gay MA, Martín J; Spanish GCA Study Group, UK GCA Consortium, Turkish Takayasu Study Group, Vasculitis Clinical Research Consortium, IgAV Study Group, AAV Study group. Ortiz-Fernández L, et al. Ann Rheum Dis. 2018 Apr;77(4):589-595. doi: 10.1136/annrheumdis-2017-212372. Epub 2018 Jan 27. Ann Rheum Dis. 2018. PMID: 29374629 Free PMC article.
CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
Rangel-Peláez C, Martínez-Gutiérrez L, Tristán-Manzano M, Callejas JL, Ortego-Centeno N, Martín F, Martín J. Rangel-Peláez C, et al. Among authors: ortego centeno n. Front Immunol. 2024 Dec 17;15:1502712. doi: 10.3389/fimmu.2024.1502712. eCollection 2024. Front Immunol. 2024. PMID: 39742256 Free PMC article. Review.
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Mar 28;12(1):5289. doi: 10.1038/s41598-022-09353-z. Sci Rep. 2022. PMID: 35347225 Free PMC article.
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Sci Rep. 2022. PMID: 35902683 Free PMC article. No abstract available.
388 results